in a phase iii study in which mtz was given in a similar schedule combined with a 7-day infusion of cytosine arabinoside ( ara-c ; 100 mg/m2/day ) , 68 % of patients were rendered leukaemia-free .
C0010711
cytosine arabinoside
C0023418
free